ELV vs IMMX · P/E 18, rev $199.13B vs $640.7M cap
Elevance Health Inc (ELV) versus Immix Biopharma Inc (IMMX) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Immix Biopharma Inc (IMMX) is a biotechnology company listed on US.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
IMMX does not have a complete income-statement cache yet.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. IMMX currently screens at market cap $640.7M.
Not investment advice. Open the ELV and IMMX stock pages for the full models.
Not investment advice.